Changing outcomes of stem cell transplantation in primary immunodeficiencies: Results from a tertiary-care charitable trust hospital in Mumbai

Changing outcomes of stem cell transplantation in primary immunodeficiencies: Results from a tertiary-care charitable trust hospital in Mumbai

Background: Hematopoietic stem cell transplantation in primary immunodeficiency disorders has come a long way since the first transplant in 1968. In India, pediatric stem cell transplantation long-term survival outcomes range from 62.5% to 75%, compared to 90% in high-income countries. Objective: We...

Full description

Bibliographic Details
Main Authors: Ambreen Pandrowala, DNB, Mukesh Desai, MD, Manisha Madkaikar, MD, Shilpa Kulkarni, MD, Lakshmi Shobhavat, DNB, Jayashree Mishra, MD, Shreepal Jain, MD, Parmarth Chandane, MD, Kunal Sehgal, MD, Saroj Chavan, DNB, Parag Karkera, MS, MCh, Pradnya Bendre, MS, MCh, Ameet Thanky, BPT, Sudha Rao, MD, Shakuntala Prabhu, MD, Minnie Bodhanwala, BDS, MBA, Bharat Agarwal, MD, Prashant Hiwarkar, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Primary immunodeficiency
stem cell transplant
primary immune regulatory disorders
outcomes
graft-versus-host disease
survival
Online Access:http://www.sciencedirect.com/science/article/pii/S2772829323000309

Internet

http://www.sciencedirect.com/science/article/pii/S2772829323000309

Similar Items